Morphine Sulfate
FDA Label NDC 27808-084

52 label sections · Submitted to the FDA by Cranbury Pharmaceuticals, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cranbury Pharmaceuticals, Llc for the product Morphine Sulfate (NDC 27808-084). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning:  serious and life-threatening risks from use of morphine sulfate oral solution, 1 indications and usage, 2.1  dosage and administration overview, 2.2  important dosage and administration instructions, 2.3  patient access to an opioid overdose reversal agent for the emergency treatment of opioid overdose, 2.4  initial dosage, 2.5  titration and maintenance of therapy, 2.6  safe reduction or discontinuation of morphine sulfate oral solution, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.